Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Liraglutide biobetter - Biolingus

Next Previous
Drug Profile

Liraglutide biobetter - Biolingus

Alternative Names: BL OPUS I

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biolingus
  • Class Anti-inflammatories; Antihyperglycaemics; Antiparkinsonians; Antirheumatics; Glucagon-like peptides; Obesity therapies
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 15 Sep 2020 Liraglutide sublingual - Biolingus is available for licensing as of 15 Sep 2020. http://www.biolingus.ch/index.html#partners
  • 15 Sep 2020 Phase I/II in Obesity in Switzerland (Sublingual) prior to September 2020 (Biolingus pipeline, September 2020)
  • 15 Sep 2020 Phase I/II in Type 2 diabetes mellitus in Switzerland (Sublingual) prior to September 2020 (Biolingus pipeline, September 2020)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top